Related Experiment Videos
A multivariate logistic regression analysis in predicting malignancy for patients with ovarian tumors
1Department of Obstetrics and Gynecology, Shimane Medical University, Izumo, Japan. hata31@shimane-med.ac.jp
Gynecologic Oncology
|May 8, 1998
Summary
This study found that elevated serum CA 125 levels and high peak systolic velocity (PSV) in ovarian tumors are key indicators for malignancy. These Doppler ultrasound findings significantly improve the preoperative diagnosis of ovarian cancer.
Area of Science:
- Gynecologic Oncology
- Medical Imaging
- Diagnostic Ultrasound
Background:
- Accurate preoperative diagnosis of ovarian malignancy is crucial for effective treatment planning.
- Gray-scale ultrasonography has limitations in differentiating benign from malignant ovarian tumors.
- Doppler ultrasound variables offer potential for improved diagnostic accuracy.
Purpose of the Study:
- To enhance the preoperative diagnosis of ovarian malignancy.
- To utilize multivariate logistic regression analysis incorporating demographic, serologic, and ultrasound variables.
- To identify key predictors of ovarian cancer.
Main Methods:
- Transvaginal ultrasound (B-mode, color, pulsed Doppler) was performed on 171 patients with ovarian tumors.
- Tumors were classified by gray-scale morphology.
- Intratumoral blood flow was assessed using resistance index (RI) and peak systolic velocity (PSV); serum CA 125 levels were measured.
Main Results:
- Unilocular cysts without flow were all benign.
- Among 101 tumors with intratumoral blood flow, multivariate analysis identified serum CA 125 levels (>= 35 U/ml) and PSV (>= 10.4 cm/s) as independent predictors of malignancy.
- A PSV of 10.4 cm/s was the median value in benign tumors.
Conclusions:
- Intratumoral PSV is a powerful tool for distinguishing benign from malignant ovarian tumors.
- Combining PSV with serum CA 125 levels improves the diagnostic accuracy for ovarian malignancy.
- These findings support the integration of Doppler ultrasound parameters in preoperative ovarian tumor assessment.